Cosette Bolsters Women’s Health, Dermatology Portfolios With Mayne Buyout

 
• By Joseph Haas

Deal Snapshot: Cosette will acquire struggling Mayne Pharma for about $430m, thereby augmenting its women’s health and dermatology portfolio and enhancing commercial capabilities.

A Business Deal
Cosette will acquire Mayne Pharma for an estimated $430m (Shutterstock)

More from Deals

More from Therapy Areas